Douglas Robert Andrew
- SEC CIK
- 0001352232
No open-market purchases or sales filed in the past year.
Current role at each company
- GMED Globus Medical IncDirectoras of Jan 23, 2026
- RMD Resmed IncSpecial Advisoras of Jan 3, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Douglas Robert Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RMD Resmed Inc
Special Advisor22 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Douglas Robert AndrewPresident and COO ResMed Inc. | SSaleResMed Common Stock | −8.00K | $248.00 | −$1.98M | −32.3%16.8K after | |
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Douglas Robert AndrewPresident and COO ResMed Inc. | SSaleResMed Common Stock | −8.00K | $275.57 | −$2.20M | −32.3%16.8K after | |
| Sep 16, 2021 (view filing) | Sep 15 | 1 day | Douglas Robert AndrewPresident and COO ResMed Inc. | SSaleResMed Common Stock | −8.00K | $291.83 | −$2.33M | −26.5%22.1K after | |
| Oct 18, 2021 (view filing) | Oct 15 | 3 days | Douglas Robert AndrewPresident and COO ResMed Inc. | SSaleResMed Common Stock | −8.00K | $255.77 | −$2.05M | −26.5%22.1K after | |
| Nov 15, 2021 (view filing) | Nov 15 | Same day | Douglas Robert AndrewPresident and COO ResMed Inc. | SSaleResMed Common Stock | −8.00K | $271.75 | −$2.17M | −27.3%21.3K after | |
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −8.00K | $256.52 | −$2.05M | −31.8%17.2K after | |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −8.00K | $247.80 | −$1.98M | −31.8%17.2K after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −8.00K | $235.81 | −$1.89M | −31.8%17.2K after | |
| Mar 16, 2022 (view filing) | Mar 15 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −8.00K | $238.07 | −$1.90M | −31.8%17.2K after | |
| Apr 19, 2022 (view filing) | Apr 18 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −8.00K | $233.29 | −$1.87M | −31.8%17.2K after |